Insider Stock Trading History of Leonhardt Harry J


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Leonhardt Harry J since year 2005. The trader's CIK number is 1286102. At the time of this reporting, Leonhardt Harry J is the SVP, GC and CCO of Halozyme Therapeutics Inc . (stock ticker symbol HTI). See this page for all insider trading activities at Halozyme Therapeutics Inc .

Note that in the past LEONHARDT HARRY J also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Leonhardt Harry J since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-04-13 HALO Halozyme Therapeutics Inc Option Ex 6,875 .00 0
2017-02-03 HALO Halozyme Therapeutics Inc Option Ex 15,413 .00 0
2016-04-13 HALO Halozyme Therapeutics Inc Option Ex 6,875 .00 0
2012-03-01 AMLN Amylin Pharmaceuticals Inc Sale 1,231 17.11 21,062
2012-02-23 AMLN Amylin Pharmaceuticals Inc Sale 2,180 17.03 37,125
2007-09-04 SNMX Senomyx Inc Sale 228 13.25 3,020
2007-07-16 SNMX Senomyx Inc Sale 1,500 13.64 20,464
2007-06-15 SNMX Senomyx Inc Sale 10,500 14.84 155,862
2007-05-15 SNMX Senomyx Inc Sale 1,500 12.47 18,703
2007-04-16 SNMX Senomyx Inc Sale 4,752 13.08 62,151
2007-01-16 SNMX Senomyx Inc Sale 1,500 12.83 19,245
2006-11-15 SNMX Senomyx Inc Sale 3,000 14.88 44,649
2006-09-15 SNMX Senomyx Inc Sale 2,500 15.04 37,602
2006-09-01 SNMX Senomyx Inc Sale 954 14.96 14,270
2006-08-15 SNMX Senomyx Inc Sale 1,000 13.40 13,405
2006-07-17 SNMX Senomyx Inc Sale 1,000 13.11 13,107
2006-05-15 SNMX Senomyx Inc Sale 1,000 12.78 12,777
2006-04-17 SNMX Senomyx Inc Sale 1,000 14.58 14,580
2006-03-15 SNMX Senomyx Inc Sale 2,000 15.78 31,560
2006-03-01 SNMX Senomyx Inc Sale 4,166 16.43 68,434
2006-02-15 SNMX Senomyx Inc Sale 9,520 15.50 147,560
2005-09-15 SNMX Senomyx Inc Sale 1,880 17.85 33,565
2005-07-26 SNMX Senomyx Inc Sale 3,212 21.16 67,965

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Leonhardt Harry J (SVP, GC and CCO of Halozyme Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.